4//SEC Filing
MCCORMICK FRANK 4
Accession 0001209191-23-012392
CIK 0001743881other
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 7:56 PM ET
Size
9.9 KB
Accession
0001209191-23-012392
Insider Transaction Report
Form 4
MCCORMICK FRANK
Director
Transactions
- Award
Stock Option (right to buy)
2023-02-21+158,814→ 158,814 totalExercise: $11.92Exp: 2033-02-20→ Common Stock (158,814 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable in three annual installments after February 21, 2023, with a final vesting date of February 21, 2026, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such date.
Documents
Issuer
BridgeBio Pharma, Inc.
CIK 0001743881
Entity typeother
Related Parties
1- filerCIK 0001257809
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 7:56 PM ET
- Size
- 9.9 KB